These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2545433)

  • 1. [Neurotensin/dopamine interactions].
    Kitabgi P; Hervé D; Studler JM; Tramu G; Rostène W; Tassin JP
    Encephale; 1989; 15 Spec No():91-4. PubMed ID: 2545433
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system.
    Lambert PD; Gross R; Nemeroff CB; Kilts CD
    Ann N Y Acad Sci; 1995 May; 757():377-89. PubMed ID: 7611695
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurotensin and dopamine interactions.
    Binder EB; Kinkead B; Owens MJ; Nemeroff CB
    Pharmacol Rev; 2001 Dec; 53(4):453-86. PubMed ID: 11734615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for the existence of interactions between receptors for dopamine and neurotensin. Dopamine reduces the affinity and increases the number of [3H]-neurotensin binding sites in the subcortical limbic forebrain of the rat.
    Agnati LF; Fuxe K; Battistini N; Giardino L; Benfenati F; Martire M; Ruggeri M
    Acta Physiol Scand; 1985 May; 124(1):125-8. PubMed ID: 2990164
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurotensin and the mesocorticolimbic dopamine system.
    Bissette G; Nemeroff CB
    Ann N Y Acad Sci; 1988; 537():397-404. PubMed ID: 2849357
    [No Abstract]   [Full Text] [Related]  

  • 7. Thirty years of dopamine research.
    Carlsson A
    Adv Neurol; 1993; 60():1-10. PubMed ID: 8093570
    [No Abstract]   [Full Text] [Related]  

  • 8. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.
    Kasckow J; Nemeroff CB
    Regul Pept; 1991 Oct; 36(2):153-64. PubMed ID: 1666685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurotensin, dopamine and mode of action of neuroleptics].
    Tassin JP
    Encephale; 1989; 15(5):465-70. PubMed ID: 2574102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses.
    Fuxe K; Agnati LF
    Med Res Rev; 1985; 5(4):441-82. PubMed ID: 2999530
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions.
    Rostene W; Azzi M; Boudin H; Lepee I; Souaze F; Mendez-Ubach M; Betancur C; Gully D
    Ann N Y Acad Sci; 1997 Apr; 814():125-41. PubMed ID: 9160965
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology and biochemistry of neurotensin receptors.
    Kitabgi P; Checler F; Mazella J; Vincent JP
    Rev Clin Basic Pharm; 1985; 5(3-4):397-486. PubMed ID: 2881326
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of glucocorticoids in dopamine-related neuropsychiatric disorders.
    Van Craenenbroeck K; De Bosscher K; Vanden Berghe W; Vanhoenacker P; Haegeman G
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):10-22. PubMed ID: 16310935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dopamine as a neurotransmittor in the central and the autonomic nervous system.
    Ungerstedt U
    Acta Endocrinol Suppl (Copenh); 1978; 216():13-26. PubMed ID: 206088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Functional morphology of mediator systems of the brain].
    Otellin VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(1):54-8. PubMed ID: 9505409
    [No Abstract]   [Full Text] [Related]  

  • 16. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
    Agid Y; Ruberg M; Javoy-Agid F; Hirsch E; Raisman-Vozari R; Vyas S; Faucheux B; Michel P; Kastner A; Blanchard V
    Adv Neurol; 1993; 60():148-64. PubMed ID: 8420132
    [No Abstract]   [Full Text] [Related]  

  • 17. Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study.
    Szigethy E; Beaudet A
    J Comp Neurol; 1989 Jan; 279(1):128-37. PubMed ID: 2563267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine hypothesis: variations on a theme (II).
    Wyatt RJ
    Psychopharmacol Bull; 1986; 22(3):923-7. PubMed ID: 3797593
    [No Abstract]   [Full Text] [Related]  

  • 19. The neurobiology of cognition in schizophrenia.
    Tamminga CA
    J Clin Psychiatry; 2006; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor pharmacology.
    Seeman P; Van Tol HH
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.